MCID: TBR022
MIFTS: 51

Tuberous Sclerosis Complex malady

Genetic diseases (common) category

Summaries for Tuberous Sclerosis Complex

About this section
Sources:
20GeneReviews, 34MalaCards
See all sources

Fully expand this MalaCard

Download this MalaCard
MalaCards: Tuberous Sclerosis Complex, also known as bourneville disease, is related to tuberous sclerosis and lymphangioleiomyomatosis. An important gene associated with Tuberous Sclerosis Complex is TSC2 (tuberous sclerosis 2), and among its related pathways are PI3K / Akt Signaling and Nanog in Mammalian ESC Pluripotency. The compounds guanosine and 2-deoxyglucose have been mentioned in the context of this disorder. Affiliated tissues include brain, kidney and cortex, and related mouse phenotypes are tumorigenesis and renal/urinary system.

GeneReviews summary for tuberous-sclerosis

Aliases & Classifications for Tuberous Sclerosis Complex

About this section
Sources:
20GeneReviews, 21GeneTests, 22Genetics Home Reference, 63UMLS
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Genetic diseases (common)


Aliases & Descriptions:

tuberous sclerosis complex 20 21 22
bourneville disease 20 22
bourneville phakomatosis 22
cerebral sclerosis 22
sclerosis tuberosa 22
tuberose sclerosis 22
tuberous sclerosis 63
epiloia 22


Related Diseases for Tuberous Sclerosis Complex

About this section
Sources:
18GeneCards, 19GeneDecks
See all sources

Diseases related to Tuberous Sclerosis Complex via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 111)
idRelated DiseaseScoreTop Affiliating Genes
1tuberous sclerosis32.2RPS6KB1, MTOR, CCL26, TSC1, TSC2
2lymphangioleiomyomatosis31.5TSC2, TSC1
3subependymal giant cell astrocytoma31.3MTOR, TSC1, TSC2
4angiomyolipoma31.3MTOR, CCL26, TSC1, TSC2
5neurofibromatosis30.9TSC2, TSC1
6polycystic kidney disease30.5MTOR, TSC2
7mental retardation30.5TSC2, TSC1, CCL26, MTOR, NTF4
8pneumothorax30.3FLCN, TSC1
9autistic disorder30.3TSC2, TSC1
10kidney angiomyolipoma30.3TSC2, TSC1, MTOR
11peutz-jeghers syndrome30.3MTOR, TSC1, TSC2
12adenocarcinoma30.2TSC2, TSC1, CCL26, RPS6KB1
13kidney cancer30.2FLCN, MTOR
14astrocytoma11.0
15cerebritis10.6
16hepatitis10.6
17giant cell tumor10.5
18pancreatitis10.5
19aneurysm10.5
20renal cell carcinoma10.5
21hemimegalencephaly10.5
22intracranial aneurysm10.4
23fibroma10.4
24neuronitis10.4
25chordoma10.4
26kidney disease10.4
27retinitis10.4
28blindness10.4
29end stage renal failure10.3
30hepatic angiomyolipoma10.3
31arachnoiditis10.3
32autism spectrum disorder10.3
33lymphedema10.3
34melanoma10.3
35neuroendocrine tumor10.3
36sleep disorder10.3
37arachnoid cysts10.3
38endotheliitis10.3
39adrenoleukodystrophy10.2
40metachromatic leukodystrophy10.2
41attention deficit hyperactivity disorder10.2
42hepatitis c10.2
43wolff-parkinson-white syndrome10.2
44rett syndrome10.2
45pulmonary edema10.2
46carpal tunnel syndrome10.2
47west syndrome10.2
48pericoronitis10.2
49von hippel-lindau disease10.2
50acne10.2

Graphical network of the top 20 diseases related to Tuberous Sclerosis Complex:



Diseases related to tuberous sclerosis complex

Symptoms for Tuberous Sclerosis Complex

About this section

Drugs & Therapeutics for Tuberous Sclerosis Complex

About this section
Sources:
6CenterWatch, 43NIH Clinical Center, 7ClinicalTrials
See all sources

Approved drugs:

Search CenterWatch for Tuberous Sclerosis Complex

Drug clinical trials:

Search ClinicalTrials for Tuberous Sclerosis Complex

Search NIH Clinical Center for Tuberous Sclerosis Complex

Search CenterWatch for Tuberous Sclerosis Complex

Genetic Tests for Tuberous Sclerosis Complex

About this section
Sources:
21GeneTests
See all sources

Genetic tests related to Tuberous Sclerosis Complex:

id Genetic test Affiliating Genes
1 Tuberous Sclerosis Complex21 TSC2

Anatomical Context for Tuberous Sclerosis Complex

About this section
Sources:
34MalaCards
See all sources

MalaCards organs/tissues related to Tuberous Sclerosis Complex:

34
Brain, Kidney, Cortex, Bone, Skin, T cells, Fetal brain, Lung, Liver, Endothelial, Adipocyte, Prostate, Smooth muscle, Testes, Eye, Caudate nucleus

Animal Models for Tuberous Sclerosis Complex or affiliated genes

About this section
Sources:
38MGI
See all sources

MGI Mouse Phenotypes related to Tuberous Sclerosis Complex:

38 (show all 11)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.8RPS6KB1, TSC1, TSC2, FLCN
2MP:00053678.3MTOR, TSC1, TSC2, FLCN
3MP:00053858.2FLCN, DUSP6, TSC2, TSC1, RPS6KB1
4MP:00053868.1SLC2A2, NTF4, MTOR, TSC1, TSC2
5MP:00053808.0FLCN, TSC2, TSC1, MTOR, RPS6KB1
6MP:00053698.0DUSP6, TSC1, MTOR, RPS6KB1, SLC2A2
7MP:00053977.4FLCN, DUSP6, TSC2, MTOR, RPS6KB1
8MP:00053767.0FLCN, DUSP6, TSC2, TSC1, MTOR, RPS6KB1
9MP:00053846.7SLC2A2, FLCN, DUSP6, TSC2, TSC1, MTOR
10MP:00053786.7FLCN, DUSP6, TSC2, TSC1, MTOR, NTF4
11MP:00107686.7FLCN, DUSP6, TSC2, TSC1, MTOR, NTF4

Publications for Tuberous Sclerosis Complex

About this section
Sources:
53PubMed
See all sources

Articles related to Tuberous Sclerosis Complex:

(show top 50)    (show all 607)
idTitleAuthorsYear
1
Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation. (22805177)
2013
2
Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex. (24271014)
2013
3
The ability of high field strength 7-T magnetic resonance imaging to reveal previously uncharacterized brain lesions in patients with tuberous sclerosis complex. (23289918)
2013
4
Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy. (23169238)
2013
5
Commentary on: everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. (23642941)
2013
6
Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations. (23391693)
2013
7
Mammalian target of rapamycin complex 1 (mTORC1) enhances bortezomib-induced death in tuberous sclerosis complex (TSC)-null cells by a c-MYC-dependent induction of the unfolded protein response. (23612979)
2013
8
Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (TSC2) mutation. (23757617)
2013
9
Arachnoid cysts in tuberous sclerosis complex. (24325802)
2013
10
Congenital Segmental Lymphedema in Tuberous Sclerosis Complex With Associated Subependymal Giant Cell Astrocytomas Treated with Mammalian Target of Rapamycin Inhibitors. (24056156)
2013
11
Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. (24053983)
2013
12
Enhanced GABAergic network and receptor function in pediatric cortical dysplasia Type IIB compared with Tuberous Sclerosis Complex. (21889982)
2012
13
Testicular cancer and the tuberous sclerosis complex. (21767201)
2012
14
Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex. (22459050)
2012
15
Clinical features distinguish childhood chordoma associated with tuberous sclerosis complex (TSC) from chordoma in the general paediatric population. (21266383)
2011
16
Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review. (21692602)
2011
17
Neuropsychological attention skills and related behaviours in adults with tuberous sclerosis complex. (21191642)
2011
18
Tuberous sclerosis complex renal disease. (21071977)
2011
19
Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex. (21507691)
2011
20
Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex. (22025691)
2011
21
Early control of seizures improves long-term outcome in children with tuberous sclerosis complex. (19369101)
2010
22
Brain lesions in tuberous sclerosis complex. Review. (20924998)
2010
23
Sirolimus therapy for fibromatosis and multifocal renal cell carcinoma in a child with tuberous sclerosis complex. (20108343)
2010
24
Prenatal diagnosis of cardiac rhabdomyomas: incidence of associated cerebral lesions of tuberous sclerosis complex. (19606448)
2009
25
TSC1 and TSC2 mutations in patients with lymphangioleiomyomatosis and tuberous sclerosis complex. (19419980)
2009
26
Prenatal molecular diagnosis of tuberous sclerosis complex. (19254590)
2009
27
Role of mutational analysis in diagnosis of tuberous sclerosis complex. (19250385)
2009
28
Prevalence of tuberous sclerosis complex in Taiwan: a national population-based study. (19887839)
2009
29
Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. (19150975)
2009
30
Epilepsy surgery and tuberous sclerosis complex: special considerations. (18759614)
2008
31
Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers. (18350576)
2008
32
Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation. (17727667)
2008
33
Behavior problems in children with tuberous sclerosis complex and parental stress. (18602868)
2008
34
Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type. (18368626)
2008
35
Tuberous sclerosis complex: a tale of two genes. (18347312)
2008
36
The correlation between 1H-MR spectroscopy and clinical manifestation with tuberous sclerosis complex. (17985261)
2007
37
The Birt-Hogg-Dube and tuberous sclerosis complex homologs have opposing roles in amino acid homeostasis in Schizosaccharomyces pombe. (17556368)
2007
38
Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity. (17942919)
2007
39
The tuberous sclerosis complex. (17205616)
2007
40
Tuberous sclerosis complex]. (17435807)
2007
41
A defect in protein farnesylation suppresses a loss of Schizosaccharomyces pombe tsc2+, a homolog of the human gene predisposing to tuberous sclerosis complex. (16624901)
2006
42
The diverse clinical manifestations of tuberous sclerosis complex: a review. (16818173)
2006
43
An adolescent girl with tuberous sclerosis complex and acne. (16783975)
2006
44
Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions. (14871804)
2004
45
Tuberous sclerosis complex: from Drosophila to human disease. (15102439)
2004
46
14-3-3beta binds to and negatively regulates the tuberous sclerosis complex 2 (TSC2) tumor suppressor gene product, tuberin. (12468542)
2003
47
Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. (12842888)
2003
48
Novel TSC1 and TSC2 mutations in Japanese patients with tuberous sclerosis complex. (12015165)
2002
49
Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients. (11904337)
2002
50
Tuberous sclerosis complex: neonatal deaths in three of four children of consanguineous, non-expressing parents. (9132502)
1997

Variations for Tuberous Sclerosis Complex

About this section
Sources:
1 National Center for Biotechnology Information (Clinvar)
See all sources

Clinvar genetic disease variations for Tuberous Sclerosis Complex:

1 (show all 22)
id Gene Name Type Significance SNP ID Assembly Location
1TSC2NM_000548.3(TSC2): c.4642delC (p.Leu1548Cysfs)deletionPathogenicrs137854083GRCh37Chr 16, 2135303: 2135303
2TSC2NM_000548.3(TSC2): c.5024C> T (p.Pro1675Leu)single nucleotide variantPathogenicrs45483392GRCh37Chr 16, 2137898: 2137898
3TSC2NM_000548.3(TSC2): c.34A> T (p.Lys12Ter)single nucleotide variantPathogenicrs45512692GRCh37Chr 16, 2098650: 2098650
4TSC2NM_000548.3(TSC2): c.2056_2059dupTACT (p.Ser687Leufs)duplicationPathogenicrs137854337GRCh37Chr 16, 2121894: 2121897
5TSC2NM_000548.3(TSC2): c.1513C> T (p.Arg505Ter)single nucleotide variantPathogenicrs45517179GRCh37Chr 16, 2114342: 2114342
6TSC2NM_000548.3(TSC2): c.1832G> A (p.Arg611Gln)single nucleotide variantPathogenic, otherrs28934872GRCh37Chr 16, 2120572: 2120572
7TSC2NM_000548.3(TSC2): c.2150T> G (p.Leu717Arg)single nucleotide variantPathogenicrs45517214GRCh37Chr 16, 2122294: 2122294
8TSC2NM_000548.3(TSC2): c.1432C> T (p.Gln478Ter)single nucleotide variantPathogenicrs121964862GRCh37Chr 16, 2113043: 2113043
9TSC2NM_000548.3(TSC2): c.4508A> C (p.Gln1503Pro)single nucleotide variantPathogenicrs45516293GRCh37Chr 16, 2134966: 2134966
10TSC2NM_000548.3(TSC2): c.5238_5255del18 (p.His1746_Arg1751del)deletionPathogenicrs137854225GRCh37Chr 16, 2138305: 2138322
11TSC2NM_000548.3(TSC2): c.2714G> A (p.Arg905Gln)single nucleotide variantPathogenicrs45517259GRCh37Chr 16, 2126143: 2126143
12TSC2NM_000548.3(TSC2): c.2713C> T (p.Arg905Trp)single nucleotide variantPathogenicrs45517258GRCh37Chr 16, 2126142: 2126142
13TSC2NM_000548.3(TSC2): c.2713C> G (p.Arg905Gly)single nucleotide variantPathogenicrs45517258GRCh37Chr 16, 2126142: 2126142
14TSC2NM_000548.3(TSC2): c.1322G> A (p.Trp441Ter)single nucleotide variantPathogenicrs45515894GRCh37Chr 16, 2112562: 2112562
15TSC1NM_000368.4(TSC1): c.1888_1891delAAAG (p.Lys630Glnfs)deletionPathogenicrs118203595GRCh37Chr 9, 135781074: 135781077
16TSC1NM_000368.4(TSC1): c.749T> A (p.Leu250Ter)single nucleotide variantPathogenicrs118203447GRCh37Chr 9, 135787833: 135787833
17TSC1NM_000368.4(TSC1): c.1760A> G (p.Lys587Arg)single nucleotide variantBenign, Pathogenicrs118203576GRCh37Chr 9, 135781205: 135781205
18TSC1NM_000368.4(TSC1): c.1904_1905delCA (p.Thr635Argfs)deletionPathogenicrs118203598GRCh37Chr 9, 135781060: 135781061
19TSC1NM_000368.4(TSC1): c.1671_1693del23 (p.Ser561Argfs)deletionPathogenicrs118203557GRCh37Chr 9, 135781272: 135781294
20TSC1NM_000368.4(TSC1): c.2194C> T (p.His732Tyr)single nucleotide variantBenign, Likely benign, Pathogenicrs118203657GRCh37Chr 9, 135779052: 135779052
21TSC1NM_000368.4(TSC1): c.671T> G (p.Met224Arg)single nucleotide variantPathogenicrs118203426GRCh37Chr 9, 135796816: 135796816
22TSC1NM_000368.4(TSC1): c.539T> C (p.Leu180Pro)single nucleotide variantPathogenicrs118203396GRCh37Chr 9, 135797330: 135797330

Expression for genes affiliated with Tuberous Sclerosis Complex

About this section
Sources:
2BioGPS, 16Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Tuberous Sclerosis Complex

Search GEO for disease gene expression data for Tuberous Sclerosis Complex.

Pathways for genes affiliated with Tuberous Sclerosis Complex

About this section
Sources:
51PathCards, 5Cell Signaling Technology, 54QIAGEN, 39NCBI BioSystems Database, 31KEGG, 52PharmGKB, 61Thomson Reuters, 56Reactome, 13EMD Millipore, 55R&D Systems
See all sources

Pathways related to Tuberous Sclerosis Complex according to GeneCards/GeneDecks:

(show all 34)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.8TSC1, TSC2
2
Show member pathways
9.4RPS6KB1, TSC1, TSC2
39.4TSC2, TSC1, RPS6KB1
4
Show member pathways
9.4TSC2, TSC1, RPS6KB1
5
Show member pathways
9.4TSC2, TSC1, RPS6KB1
6
Show member pathways
IL2 signaling events mediated by STAT539
9.2RPS6KB1, MTOR
79.2MTOR, RPS6KB1
89.2RPS6KB1, MTOR
9
Show member pathways
9.1SLC2A2, MTOR
10
Show member pathways
Signaling Pathways in Glioblastoma39
9.0MTOR, TSC1, TSC2
119.0MTOR, TSC1, TSC2
12
Show member pathways
Prostate Cancer39
Integrated Cancer pathway39
Steroid Biosynthesis39
9.0MTOR, TSC1, TSC2
139.0MTOR, TSC1, TSC2
14
Show member pathways
9.0TSC2, TSC1, CCL26, RPS6KB1
15
Show member pathways
Signal transduction PTEN pathway61
8.9RPS6KB1, MTOR, TSC2
168.9RPS6KB1, MTOR, TSC2
178.9RPS6KB1, MTOR, TSC2
18
Show member pathways
Development Role of HDAC and calcium calmodulin dependent kinase CaMK in control of skeletal myogenesis61
8.9RPS6KB1, MTOR, TSC2
19
Show member pathways
Cytoskeleton remodeling FAK signaling61
Development Endothelin 1 EDNRA transactivation of EGFR61
8.9TSC2, MTOR, RPS6KB1
20
Show member pathways
Development Activation of ERK by Alpha 1 adrenergic receptors61
8.9TSC2, MTOR, RPS6KB1
21
Show member pathways
Translation Non genomic rapid action of Androgen Receptor61
8.9TSC2, MTOR, RPS6KB1
228.8CCL26, MTOR, RPS6KB1
23
Show member pathways
8.8DUSP6, TSC2, MTOR
24
Show member pathways
Prolactin Signaling Pathway39
Development Prolactin receptor signaling61
Leptin signaling pathway39
8.7MTOR, RPS6KB1, SLC2A2
258.5RPS6KB1, MTOR, TSC1, TSC2
26
Show member pathways
Immune response IL 4 signaling pathway61
Signal transduction AKT signaling61
8.5RPS6KB1, MTOR, TSC1, TSC2
278.5RPS6KB1, MTOR, TSC1, TSC2
28
Show member pathways
Transcription Receptor mediated HIF regulation61
Development CNTF receptor signaling61
Class IB PI3K non-lipid kinase events39
ErbB2/ErbB3 signaling events39
Development Growth hormone signaling via PI3K AKT and MAPK cascades61
Translation Regulation activity of EIF261
Regulation of lipid metabolism Insulin signaling generic cascades61
Transcription PPAR Pathway61
Cell adhesion PLAU signaling61
Translation Regulation activity of EIF4F61
8.5RPS6KB1, MTOR, TSC1, TSC2
298.5TSC2, TSC1, MTOR, RPS6KB1
30
Show member pathways
mTOR signaling pathway39
8.5TSC2, TSC1, MTOR, RPS6KB1
318.5TSC2, TSC1, MTOR, RPS6KB1
32
Show member pathways
8.5TSC2, TSC1, MTOR, RPS6KB1
33
Show member pathways
8.0RPS6KB1, MTOR, TSC1, TSC2, DUSP6
347.9RPS6KB1, MTOR, TSC1, TSC2, FLCN

Compounds for genes affiliated with Tuberous Sclerosis Complex

About this section
Sources:
46Novoseek, 25HMDB, 12DrugBank, 30IUPHAR, 62Tocris Bioscience, 52PharmGKB
See all sources

Compounds related to Tuberous Sclerosis Complex according to GeneCards/GeneDecks:

(show all 26)
idCompoundScoreTop Affiliating Genes
1guanosine46 25 1211.5TSC1, TSC2
22-deoxyglucose46 1210.5SLC2A2, RPS6KB1
3phenylephrine46 30 25 1212.5RPS6KB1, DUSP6
4paraffin469.4SLC2A2, TSC1, TSC2
5aicar46 25 1211.4RPS6KB1, MTOR
6okadaic acid46 6210.2RPS6KB1, MTOR, TSC2
7forskolin46 52 1211.2NTF4, RPS6KB1, SLC2A2
8ly294002469.1RPS6KB1, MTOR, TSC2
9wortmannin469.1TSC2, MTOR, RPS6KB1
10everolimus46 52 1210.9RPS6KB1, MTOR, TSC1, TSC2
11phosphoinositide468.9TSC2, TSC1, MTOR, RPS6KB1
12vegf468.8TSC2, TSC1, MTOR, RPS6KB1
13threonine468.8TSC2, TSC1, MTOR, RPS6KB1
14cisplatin46 52 62 1211.7MTOR, NTF4, RPS6KB1
15pd 98,059468.7RPS6KB1, MTOR, TSC1, DUSP6
16leucine468.7TSC2, MTOR, RPS6KB1, SLC2A2
17arginine468.7SLC2A2, NTF4, MTOR, TSC2
18phosphatidylinositol468.5TSC2, TSC1, MTOR, NTF4, RPS6KB1
19serine468.4TSC2, TSC1, MTOR, NTF4, RPS6KB1
20glycogen46 259.4TSC2, TSC1, MTOR, RPS6KB1, SLC2A2
21glucose468.3TSC2, TSC1, MTOR, RPS6KB1, SLC2A2
22oxygen46 259.3DUSP6, TSC2, CCL26, MTOR, RPS6KB1
23atp46 309.3SLC2A2, RPS6KB1, MTOR, CCL26, TSC2
24calcium46 52 25 1211.0DUSP6, CCL26, MTOR, NTF4, RPS6KB1
25tyrosine467.9DUSP6, TSC2, TSC1, MTOR, NTF4, RPS6KB1
26rapamycin467.9FLCN, TSC2, TSC1, CCL26, MTOR, RPS6KB1

GO Terms for genes affiliated with Tuberous Sclerosis Complex

About this section
Sources:
17Gene Ontology
See all sources

Cellular components related to Tuberous Sclerosis Complex according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1TSC1-TSC2 complexGO:0335969.8TSC1, TSC2
2membraneGO:0160208.2TSC2, TSC1, MTOR, SLC2A2
3cytosolGO:0058298.0RPS6KB1, MTOR, TSC1, TSC2, DUSP6
4cytoplasmGO:0057376.8FLCN, DUSP6, TSC2, TSC1, MTOR, RPS6KB1

Biological processes related to Tuberous Sclerosis Complex according to GeneCards/GeneDecks:

(show all 19)
idNameGO IDScoreTop Affiliating Genes
1cell projection organizationGO:03003010.0TSC1, TSC2
2protein kinase B signalingGO:0434919.9TSC2, RPS6KB1
3long-term memoryGO:0076169.9RPS6KB1, NTF4
4protein heterooligomerizationGO:0512919.8TSC1, TSC2
5negative regulation of protein kinase B signalingGO:0518989.8TSC2, FLCN
6regulation of protein kinase activityGO:0458599.6TSC1, MTOR
7negative regulation of ERK1 and ERK2 cascadeGO:0703739.6FLCN, DUSP6
8neural tube closureGO:0018439.5TSC1, TSC2
9negative regulation of TOR signalingGO:0320079.5TSC1, TSC2, FLCN
10positive regulation of actin filament polymerizationGO:0308389.4CCL26, MTOR
11germ cell developmentGO:0072819.3RPS6KB1, MTOR
12negative regulation of cell sizeGO:0457929.3MTOR, TSC1, TSC2
13positive regulation of translationGO:0457279.3RPS6KB1, MTOR
14response to nutrientGO:0075849.2RPS6KB1, MTOR
15positive regulation of endothelial cell proliferationGO:0019389.2CCL26, MTOR
16phosphatidylinositol-mediated signalingGO:0480159.2RPS6KB1, MTOR, TSC2
17neurotrophin TRK receptor signaling pathwayGO:0480119.0DUSP6, TSC2, MTOR
18TOR signalingGO:0319298.9FLCN, MTOR, RPS6KB1
19insulin receptor signaling pathwayGO:0082868.8TSC2, TSC1, MTOR, RPS6KB1

Products for genes affiliated with Tuberous Sclerosis Complex

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Tuberous Sclerosis Complex

About this section
4CDC
14ExPASy
15FMA
23GTR
24HGMD
25HMDB
26ICD10
27ICD10 via Orphanet
28ICD9CM
30IUPHAR
31KEGG
36MeSH
37MESH via Orphanet
38MGI
41NCIt
42NDF-RT
45NINDS
46Novoseek
48OMIM
49OMIM via Orphanet
53PubMed
54QIAGEN
60SNOMED-CT via Orphanet
63UMLS
64UMLS via Orphanet